| ARID3B | AT-rich interaction domain–containing protein 3B |
| ARID3A | AT-rich interaction domain–containing protein 3A |
| WT | Wild-type |
| S89 | Serine 89 |
| S89A | Serine 89 to alanine mutant (phospho-dead) |
| S89D | Serine 89 to aspartic acid mutant (phosphomimetic) |
| Phospho-S89 | Phosphorylated ARID3B at serine 89 |
| GFP | Green fluorescent protein |
| SDM | Site-directed mutagenesis |
| IP | Immunoprecipitation |
| IB | Immunoblot |
| ChIP | Chromatin immunoprecipitation |
| IF | Immunofluorescence |
| IHC | Immunohistochemistry |
| RNA-seq | RNA sequencing |
| RT-qPCR | Reverse transcription quantitative polymerase chain reaction |
| EGFR | Epidermal growth factor receptor |
| NES | Nestin |
| PROM1 | Prominin-1 (CD133) |
| PROM2 | Prominin-2 |
| TNF | Tumor necrosis factor |
| TNFR2 | Tumor necrosis factor receptor 2/TNFRSF1B |
| WNT4 | Wingless-type MMTV integration site family member 4 |
| MYCN | MYCN proto-oncogene |
| CSCs | Cancer stem cells |
| PTM | Post-translational modifications |